Xiaofei Zhou

4.6k citations

99 papers · 3.3k indexed · 1 hit paper · h-index 32

Impact in

Immunology top 2%
- Immune Cell Function and Interaction
- Immune cells in cancer
- T-cell and B-cell Immunology
- interferon and immune responses
- Immune Response and Inflammation
Cancer Research top 2%
- NF-κB Signaling Pathways
- Cancer, Hypoxia, and Metabolism

Papers in ⓘ

Immunology 38
- Immune Cell Function and Interaction 19
- Immunotherapy and Immune Responses 10
- interferon and immune responses 7
Molecular Biology 36
- Ubiquitin and proteasome pathways 9

Co-authors: Shao‐Cong Sun (26 shared papers)Xuhong Cheng (23 shared papers)Yichuan Xiao (9 shared papers)Mikyoung Chang (6 shared papers)Jae‐Hoon Chang (6 shared papers)Mako Nakaya (5 shared papers)Marzenna Blonska (1 shared paper)Xin Lin (1 shared paper)
Journals: Nature Immunology (7 papers)Nature Communications (4 papers)World Neurosurgery (4 papers)Cancer Research (3 papers)PLoS ONE (3 papers)
Partner nations: China United States South Korea

In The Last Decade

Xiaofei Zhou

90 papers receiving 3.3k citations

Hit Papers

align trajectories log scale

Inflammatory T Cell Responses Rely on Amino Acid Transporter ASCT2 Facilitation of Glutamine Uptake and mTORC1 Kinase Activation 2014 · 652 citations

Peers

Countries citing papers authored by Xiaofei Zhou

Since Specialization

Citations

This map shows the geographic impact of Xiaofei Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofei Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofei Zhou more than expected).

Fields of papers citing papers by Xiaofei Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaofei Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofei Zhou. The network helps show where Xiaofei Zhou may publish in the future.

Co-authors

The 25 scholars most cited alongside Xiaofei Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiaofei Zhou Line = papers co-authored together Xiaofei Zhou links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 99 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Inflammatory T Cell Responses Rely on Amino Acid Transporter ASCT2 Facilitation of Glutamine Uptake and mTORC1 Kinase Activation Immunity ·Mako Nakaya, Yichuan Xiao, Xiaofei Zhou, Jae‐Hoon Chang, Mikyoung Chang, Xuhong Cheng, Marzenna Blonska, Xin Lin, Shao‐Cong Sun Hit paper breakdown →	2014	652
2	USP15 stabilizes MDM2 to mediate cancer-cell survival and inhibit antitumor T cell responses Nature Immunology ·Qiang Zou, Jin Jin, Hongbo Hu, Haiyan S. Li, Simona Romano, Yichuan Xiao, Mako Nakaya, Xiaofei Zhou, Xuhong Cheng, Peirong Yang, Guillermina Lozano, Chengming Zhu, Stephanie S. Watowich, Stephen E. Ullrich, Shao‐Cong Sun	2014	198
3	Peli1 promotes microglia-mediated CNS inflammation by regulating Traf3 degradation Nature Medicine ·Yichuan Xiao, Jin Jin, Mikyoung Chang, Jae‐Hoon Chang, Hongbo Hu, Xiaofei Zhou, George C. Brittain, C. T. Stansberg, Øivind Torkildsen, Xiaodong Wang, Robert Brink, Xuhong Cheng, Shao‐Cong Sun	2013	152
4	The ubiquitin ligase Peli1 negatively regulates T cell activation and prevents autoimmunity Nature Immunology ·Mikyoung Chang, Wei Jin, Jae‐Hoon Chang, Yichuan Xiao, George C. Brittain, Jiayi Yu, Xiaofei Zhou, Yi-Hong Wang, Xuhong Cheng, Pingwei Li, Brian Rabinovich, Patrick Hwu, Shao‐Cong Sun	2011	147
5	Ubc13 maintains the suppressive function of regulatory T cells and prevents their conversion into effector-like T cells Nature Immunology ·Jae‐Hoon Chang, Yichuan Xiao, Hongbo Hu, Jin Jin, Jiayi Yu, Xiaofei Zhou, Xuefeng Wu, Howard M. Johnson, Shizuo Akira, Manolis Pasparakis, Xuhong Cheng, Shao‐Cong Sun	2012	114
6	Two-Dimensional Transition Metal Dichalcogenides: Synthesis, Biomedical Applications and Biosafety Evaluation Frontiers in Bioengineering and Biotechnology ·Xiaofei Zhou, Hainan Sun, Xue Bai	2020	93
7	LncRNAs Expression in Preeclampsia Placenta Reveals the Potential Role of LncRNAs Contributing to Preeclampsia Pathogenesis PLoS ONE ·He Xiaoju, Yinyan He, Binrong Xi, Jiusheng Zheng, Xiaoming Zeng, Qinhua Cai, Yu Ouyang, Chen Wang, Xiaofei Zhou, Huiying Huang, Wei Deng, Siming Xin, Qixiang Huang, Huai Liu	2013	92
8	Regulation of T-cell activation and migration by the kinase TBK1 during neuroinflammation Nature Communications ·Jiayi Yu, Xiaofei Zhou, Mikyoung Chang, Mako Nakaya, Jae‐Hoon Chang, Yichuan Xiao, John Lindsey, Stephanie Dorta‐Estremera, Wei Cao, Malgorzata Anna Zal, Tomasz Żal, Shao‐Cong Sun	2015	89
9	NF-κB-inducing kinase maintains T cell metabolic fitness in antitumor immunity Nature Immunology ·Meidi Gu, Xiaofei Zhou, Jee Hyung Sohn, Lele Zhu, Zuliang Jie, Jin‐Young Yang, Xiaofeng Zheng, Xiaoping Xie, Jie Yang, Yaoyao Shi, Hans D. Brightbill, Jae Bum Kim, Jing Wang, Xuhong Cheng, Shao‐Cong Sun	2021	81
10	The deubiquitinase Otub1 controls the activation of CD8+ T cells and NK cells by regulating IL-15-mediated priming Nature Immunology ·Xiaofei Zhou, Jiayi Yu, Xuhong Cheng, Baoyu Zhao, Ganiraju C. Manyam, Li Zhang, Kimberly S. Schluns, Pingwei Li, Jing Wang, Shao‐Cong Sun	2019	78
11	Peptidyl-prolyl cis/trans isomerase Pin1 is critical for the regulation of PKB/Akt stability and activation phosphorylation Oncogene ·Yong Liao, YinYin Wei, Xiaofei Zhou, Jinling Yang, Chengkai Dai, Y J Chen, Nitin Agarwal, Dos D. Sarbassov, Da Shi, Dihua Yu, Mien‐Chie Hung	2009	77
12	NEW 4-ARYL-1,4-DIHYDROPYRIDINES AND 4-ARYLPYRIDINES AS P-GLYCOPROTEIN INHIBITORS Drug Metabolism and Disposition ·Xiaofei Zhou, Linping Zhang, Elaine Tseng, Elizabeth Scott-Ramsay, Jerome J. Schentag, Robert A. Coburn, Marilyn E. Morris	2004	64
13	TBKBP1 and TBK1 form a growth factor signalling axis mediating immunosuppression and tumourigenesis Nature Cell Biology ·Lele Zhu, Yanchuan Li, Xiaoping Xie, Xiaofei Zhou, Meidi Gu, Zuliang Jie, Chun‐Jung Ko, Tianxiao Gao, Blanca E. Hernandez, Xuhong Cheng, Shao‐Cong Sun	2019	61
14	TPL2 mediates autoimmune inflammation through activation of the TAK1 axis of IL-17 signaling The Journal of Experimental Medicine ·Yichuan Xiao, Jin Jin, Mikyoung Chang, Mako Nakaya, Hongbo Hu, Qiang Zou, Xiaofei Zhou, George C. Brittain, Xuhong Cheng, Shao‐Cong Sun	2014	58
15	Targeting ubiquitin signaling for cancer immunotherapy Signal Transduction and Targeted Therapy ·Xiaofei Zhou, Shao‐Cong Sun	2021	56
16	The critical role of SENP1-mediated GATA2 deSUMOylation in promoting endothelial activation in graft arteriosclerosis Nature Communications ·Cong Qiu, Yuewen Wang, Haige Zhao, Lingfeng Qin, Yanna Shi, Xiaolong Zhu, Lin Song, Xiaofei Zhou, Jian Chen, Hong Zhou, Haifeng Zhang, George Tellides, Min Wang, Luyang Yu	2017	55
17	Cell intrinsic role of NF-κB-inducing kinase in regulating T cell-mediated immune and autoimmune responses Scientific Reports ·Yanchuan Li, Hui Wang, Xiaofei Zhou, Xiaoping Xie, Xiang Chen, Zuliang Jie, Qiang Zou, Hongbo Hu, Lele Zhu, Xuhong Cheng, Hans D. Brightbill, Lawren C. Wu, Linfang Wang, Shao‐Cong Sun	2016	52
18	Electrochemical Sizing of Organic Nanoparticles Angewandte Chemie ·Wei Cheng, Xiaofei Zhou, Richard G. Compton	2013	49
19	EFFECTS OF DIHYDROPYRIDINES AND PYRIDINES ON MULTIDRUG RESISTANCE MEDIATED BY BREAST CANCER RESISTANCE PROTEIN: IN VITRO AND IN VIVO STUDIES Drug Metabolism and Disposition ·Xiaofei Zhou, Xinning Yang, Qi Wang, Robert A. Coburn, Marilyn E. Morris	2005	47
20	Chestnut-like CoFe2O4@SiO2@In2O3 nanocomposite microspheres with enhanced acetone sensing property Sensors and Actuators B Chemical ·Guo Lin, Hong Wang, Xuefei Li, Xiaoyong Lai, Yanzhao Zou, Xiaofei Zhou, Di Liu, Jiawei Wan, Hong Xin	2017	47

About Xiaofei Zhou

Xiaofei Zhou is a scholar working on Immunology, Molecular Biology, Oncology, Cancer Research and Epidemiology, having authored 99 papers that have together received 3.3k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (19 papers), Immunotherapy and Immune Responses (10 papers), Ubiquitin and proteasome pathways (9 papers), NF-κB Signaling Pathways (8 papers), interferon and immune responses (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), Autophagy in Disease and Therapy (6 papers) and CAR-T cell therapy research (6 papers). The work is most often cited by research in Immunology (1.4k citations), Cancer Research (742 citations), Oncology (737 citations), Molecular Biology (1.5k citations) and Biological Psychiatry (46 citations). Xiaofei Zhou has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Shao‐Cong Sun, Xuhong Cheng, Yichuan Xiao, Mikyoung Chang, Jae‐Hoon Chang, Mako Nakaya, Marzenna Blonska, Xin Lin, Hongbo Hu and Jin Jin. Their work appears in journals such as Nature Immunology, Nature Communications, World Neurosurgery, Cancer Research and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact